Hsiue H.-C.NI-CHUNG LEEHUNG-BIN TSAICHIH-CHAO YANGWu C.-S.WANG-TSO LEEWEN-CHIN WENGHung K.-L.Huang C.-C.WUH-LIANG HWUPI-CHUAN FANYIN-HSIU CHIENChen C.-H.Lin S.-J.Chu S.-Y.Wang T.-J.Lu C.-J.PEI-LIN LEE2020-07-202020-07-202015-08-240342-4642https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937815807&doi=10.1007%2fs00134-015-3879-x&partnerID=40&md5=08cd069b30d6e77fa1aec0e1c7717e8bhttps://scholars.lib.ntu.edu.tw/handle/123456789/510196[SDGs]SDG3etiracetam; phenytoin; valproic acid; mitochondrial DNA; clinical article; cohort analysis; continuous renal replacement therapy; diabetic ketoacidosis; disability; disorders of mitochondrial functions; drug substitution; drug withdrawal; follow up; human; intensive care; lactic acidosis; length of stay; Letter; mortality; myopathy; Rankin scale; retrospective study; seizure; genetics; intensive care; MELAS syndrome; mortality; mutation; survival analysis; Taiwan; Cohort Studies; Critical Care; DNA, Mitochondrial; Humans; MELAS Syndrome; Mutation; Retrospective Studies; Survival Analysis; Taiwanletter10.1007/s00134-015-3879-x260770742-s2.0-84937815807